Cargando…
Correction: Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)
Autores principales: | Phinyo, Phichayut, Maihom, Titinat, Phanphaisarn, Areerak, Kerdsinchai, Pakorn, Rattarittamrong, Ekarat, Patumanond, Jayanton, Pruksakorn, Dumnoensun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331149/ https://www.ncbi.nlm.nih.gov/pubmed/35902790 http://dx.doi.org/10.1186/s12875-022-01785-w |
Ejemplares similares
-
Development of a clinical diagnostic tool to differentiate multiple myeloma from bone metastasis in patients with destructive bone lesions (MM-BM DDx)
por: Phinyo, Phichayut, et al.
Publicado: (2020) -
Validation of a Diagnostic Model to Differentiate Multiple Myeloma from Bone Metastasis
por: Phinyo, Phichayut, et al.
Publicado: (2023) -
Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review
por: Orrapin, Santhasiri, et al.
Publicado: (2022) -
IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma
por: Chaiyawat, Parunya, et al.
Publicado: (2021) -
Natural disease progression and novel survival prediction model for hepatocellular carcinoma with spinal metastases: a 10-year single-center study
por: Phinyo, Phichayut, et al.
Publicado: (2020)